Hims & Hers Stock Surges 16% on Expansion into Women’s Healthcare Segment
Hims & Hers Health (HIMS) shares rallied 16.2% Wednesday, dramatically outperforming the S&P 500's 0.4% gain, after announcing its entry into the perimenopause and menopause care market. The digital health platform aims to address what it calls systemic gaps in women's healthcare through personalized treatment plans.
The MOVE opens access to an estimated 1.3 million potential patients in the US market. "Women have been navigating an outdated healthcare system that wasn't designed for them for too long," said Chief Medical Officer Jessica Shepherd, positioning the initiative as part of the company's broader mission to transform patient-centric care.